FRM
Fox Run Management’s HCA Healthcare HCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-8,115
| Closed | -$2.61M | – | 927 |
|
2024
Q2 | $2.61M | Buy |
+8,115
| New | +$2.61M | 0.49% | 4 |
|
2024
Q1 | – | Sell |
-2,774
| Closed | -$751K | – | 896 |
|
2023
Q4 | $751K | Buy |
+2,774
| New | +$751K | 0.19% | 164 |
|
2023
Q2 | – | Sell |
-1,998
| Closed | -$527K | – | 798 |
|
2023
Q1 | $527K | Buy |
+1,998
| New | +$527K | 0.17% | 207 |
|
2022
Q4 | – | Sell |
-5,058
| Closed | -$930K | – | 741 |
|
2022
Q3 | $930K | Buy |
+5,058
| New | +$930K | 0.36% | 30 |
|
2022
Q1 | – | Sell |
-986
| Closed | -$253K | – | 591 |
|
2021
Q4 | $253K | Sell |
986
-208
| -17% | -$53.4K | 0.15% | 287 |
|
2021
Q3 | $290K | Buy |
1,194
+90
| +8% | +$21.9K | 0.18% | 247 |
|
2021
Q2 | $228K | Buy |
+1,104
| New | +$228K | 0.21% | 249 |
|
2020
Q2 | – | Sell |
-2,829
| Closed | -$254K | – | 282 |
|
2020
Q1 | $254K | Buy |
2,829
+1,450
| +105% | +$130K | 0.6% | 45 |
|
2019
Q4 | $204K | Sell |
1,379
-1,889
| -58% | -$279K | 0.16% | 324 |
|
2019
Q3 | $394K | Buy |
3,268
+717
| +28% | +$86.4K | 0.36% | 78 |
|
2019
Q2 | $345K | Buy |
+2,551
| New | +$345K | 0.23% | 175 |
|
2018
Q4 | – | Sell |
-4,497
| Closed | -$626K | – | 593 |
|
2018
Q3 | $626K | Buy |
4,497
+2,245
| +100% | +$313K | 0.27% | 102 |
|
2018
Q2 | $231K | Sell |
2,252
-3,436
| -60% | -$352K | 0.07% | 528 |
|
2018
Q1 | $552K | Sell |
5,688
-2,556
| -31% | -$248K | 0.13% | 282 |
|
2017
Q4 | $724K | Buy |
+8,244
| New | +$724K | 0.21% | 151 |
|
2017
Q3 | – | Sell |
-3,600
| Closed | -$314K | – | 748 |
|
2017
Q2 | $314K | Sell |
3,600
-2,468
| -41% | -$215K | 0.11% | 392 |
|
2017
Q1 | $540K | Buy |
6,068
+2,668
| +78% | +$237K | 0.22% | 157 |
|
2016
Q4 | $252K | Sell |
3,400
-2,600
| -43% | -$193K | 0.13% | 356 |
|
2016
Q3 | $454K | Buy |
+6,000
| New | +$454K | 0.27% | 128 |
|
2016
Q2 | – | Sell |
-8,300
| Closed | -$648K | – | 589 |
|
2016
Q1 | $648K | Buy |
+8,300
| New | +$648K | 0.43% | 35 |
|